• Clinical and Experimental Pediatrics
• /
• 제52권8호
• /
• pp.922-929
• /
• 2009

목 적 : 성장 장애는 영아 및 소아에서 성장 속도가 같은 성별, 연령 보다 현저히 작은 경우를 지칭하며 여러 가지 원인에 의해서 발생할 수 있다. 저신장을 주소로 내원한 환자 중 성장 장애를 보이지만 성장호르몬 자극검사가 정상인 환자들의 임상적 특성 및 성장호르몬 치료에 대한 반응을 알아보고자 하였다. 방 법 : 1990년 1월부터 2008년 6월까지 서울대학교 어린이병원 소아청소년과에 내원한 어린이 중에서 성장속도가 연간 4 cm 미만이면서, 2가지 서로 다른 약제로 성장호르몬 자극검사를 시행하였을 때 정상 소견을 보이는 환자를 대상으로 하였다. SGA군과 AGA군으로 나누어 임상적인 특성을 비교하였으며, 성장호르몬 투여군에 대한 분석을 시행하였다. 결 과 : 총 39명의 환자가 연구에 포함되었으며, 남자가 25명(64%), 여자 14명(36%)이었고, SGA군 11명(28%), AGA군 28명(72%), 성장호르몬 투여군 16명(41%), 비 투여군 23명(59%)이었다. SGA군과 AGA군 모두에서 골연령이 역연령에 비하여 지연되어 있었으나(P=0.028), 두 군간의 차이는 없었다. 모든 환자에서 성장호르몬 자극검사 후 성장호르몬의 최고 농도는 10 ng/mL 이상이었고, clonidine을 사용하였을 때 성장호르몬의 최고농도가 30.4 (6.2, 92.0) ng/mL로 다른 약제에 비하여 유의하게 높았다(P=0.03). 성장호르몬 치료받은 환자 16명의 1년간 성장 속도는 7.7 (4.9, 11.1) cm/yr, 치료 받지 않고 추적관찰 된 6명은 3.7 (2.7, 4.5) cm/yr으로 유의한 차이가 있었다(P<0.001). 또한 성장호르몬 투여군에서 치료 1년 동안 신장 SDS는 0.3 (-0.1, 0.9) 증가하였고(P<0.001), 성장 속도의 변화는 4.8 (2.1, 7.7) cm/yr로 의미있게 증가하였다(P<0.001). 성장호르몬으로 치료받은 환자 중, 치료 후 1년간 성장속도는 SGA군에서 7.1 (5.1, 8.5) cm/yr, AGA군에서 8.2 (4.9, 11.1) cm/yr로 두 군 모두에서 성장호르몬 사용 전 1년 간의 성장 속도보다는 유의하게 증가하였다. 성장호르몬 치료를 시작할 때의 신장의 SDS가 -3 이상인 군과 -3 미만인 군으로 나누어 분석해 보았을 때, 성장호르몬 자극검사시의 IGF-I 농도가 SDS가 -3 미만인 군에서 유의하게 낮게 측정되었다(P=0.023). 결 론 : 성장 속도가 연간 4 cm 미만으로 감소하였으나 성장호르몬 자극검사가 정상인 환자들이 단기간의 성장호르몬 투여로 성장 속도의 증가가 있었으나 이들에서의 장기적인 성장호르몬 효과에 대하여는 향후 더 추적관찰이 필요하다. 또한 이들에서 부분적 인 성장호르몬 저항성 증후군의 가능성이 있으므로, 추후 이러한 환자들을 대상으로 IGF-I 생성 검사를 포함한, GH-IGF-I 축에 대한 검사를 시행하여 성장 장애의 원인을 밝혀야 할 것이다.

• 한국보건간호학회지
• /
• 제17권2호
• /
• pp.224-237
• /
• 2003

Purpose : This study was designed to describe the relationship on climacteric symptom and health behavior according to hormone replacement therapy (HRT) in climacteric women. Method : Data were collected through self-reported questionaries which were constructed to include a climacteric symptom and health behaviors of climacteric women. The subjects for this study were 135 climacteric women between 45-65 years of age living in Kuri city. Among them. 65 were in the experimental group and the other 70 were in the control group. The data were analyzed by descriptive statistics, t-test, $x^2-test$, ANOVA, and Pearson Correlation Coefficient. Results : The results were as follows 1) There was no significant difference on the climacteric symptom between the group of women receiving HRT and those who did not (t=1.973, p=0.162). 2) The mean health behavior score for the group of women receiving HRT was significantly higher than those who did not(t=2.557, p=0.042). 3) The climacteric symptom and health behavior were positively correlated (r=.289, p=0.015) in women receiving HRT, while these were negatively correlated (r=-.242, p=0.043) in women without HRT. 4) Women in the HRT group showed higher climacteric symptom than the those In the control group in most items. 5) The mean score for health behavior was 2.76 in the hormone replacement therapy group and 2.35 for the control group. 6) For women in the experimental group, climacteric symptom was significantly different by the level of education (F=7.371, p=.001). 7) For women in the control group, climacteric symptom was significantly different by the number of children (F=2.873, p=.044), the level of education (F=5.616, p=.006), the number of abortion (F=3.231, p=.015), and the status of menstruation (F=4.129, p=.020). 8) For women in the experimental group, health behavior was significantly different by the level of education (F=7.351, p=.001), frequency of exercise (F=8.106, p=.000), and the status of menstruation (F=3.446, p=.032), 9) For women in the control group, health behavior was significantly different by frequency of the exercise (F=7.381, p=.001). Conclusion : This study results indicated that there was no association between the HRT and climacteric symptoms, while there was positive correlations between the HRT and health behavior. Therefore. it is assumed that HRT increases the positive health behavior of women.

• Clinical and Experimental Pediatrics
• /
• 제62권3호
• /
• pp.85-89
• /
• 2019

Purpose: We compared thyroid hormone profiles in children with nephrotic syndrome (NS) during the nephrotic phase and after remission. Methods: This study included 31 pediatric NS patients. The thyroid hormone profiles included serum levels of triiodothyronine (T3), thyroxine (T4), thyroid-stimulating hormone (TSH), and free T4. Results: Of the 31 patients, 16 (51.6%) showed abnormal thyroid hormone profiles: 6 had overt hypothyroidism, 8 had subclinical hypothyroidism, and 2 had low T3 syndrome. The mean serum T3, T4, and free T4 levels in the nephrotic phase and after remission were $82.37{\pm}23.64$ and $117.88{\pm}29.49ng/dL$, $5.47{\pm}1.14$ and $7.91{\pm}1.56{\mu}g/dL$, and $1.02{\pm}0.26$ and $1.38{\pm}0.23ng/dL$, respectively; the levels were significantly lower in the NS nephrotic phase (P=0.0007, P<0.0001, and P=0.0002). The mean serum TSH levels during the nephrotic phase and after remission were $8.05{\pm}3.53$ and $4.08{\pm}2.05{\mu}IU/mL$, respectively; they were significantly higher in the nephrotic phase (P=0.0005). The urinary protein/creatinine ratio during the nephrotic phase was significantly correlated with serum T3, T4, and free T4 levels (r=-0.5995, P=0.0032; r=-0.5797, P=0.0047; r=-0.5513, P=0.0078) as well as with TSH levels (r=0.5022, P=0.0172). A significant correlation was found between serum albumin and serum T3 levels during the nephrotic phase (r=0.5385, P=0.0018) but not between serum albumin and T4, TSH, or free T4 levels. These significant correlations all disappeared after remission. Conclusion: Abnormal thyroid hormone profile findings were observed in 51.6% of pediatric patients with NS. Thyroid hormone levels normalized after remission, regardless of levothyroxine therapy.

• Journal of Yeungnam Medical Science
• /
• 제31권2호
• /
• pp.148-151
• /
• 2014

Radioactive iodine (RAI) therapy is widely used for the treatment of Graves disease. After RAI therapy, 44% become hypothyroid and up to 28% remain hyperthyroid. The development of thyrotoxicosis after RAI therapy is believed to be mediated by 2 different mechanisms: a transient increased release of thyroid hormone due to radiation thyroiditis and the rare development of Graves disease due to the formation of antibodies to the thyroid-associated antigens released from the damaged follicular cells. A 55-year-old woman was hospitalized with severe headache, weight loss, and palpitation. She received a dose of 7 mCi of RAI (I-131) about 6 weeks earlier. Thyroid function test showed 7.98 ng/dL free T4, >8 ng/mL T3, < $0.08{\mu}IU/L$ thyroid stimulating hormone, and high titer thyroid stimulating immunoglobulin (TSI) (85.8 IU/L). She improved with propylthiouracil, propranolol, and steroid treatment. The TSI, however, was persistently elevated for 11 months.

• Clinical and Experimental Pediatrics
• /
• 제59권4호
• /
• pp.202-204
• /
• 2016

A 15-year-old boy, who was diagnosed with Alport syndrome and end-stage renal disease, received a renal transplant from a living-related donor. On postoperative day 1, his daily urine output was 10,000 mL despite normal graft function. His laboratory findings including urine, serum osmolality, and antidiuretic hormone levels showed signs similar to central diabetes insipidus, so he was administered desmopressin acetate nasal spray. After administering the desmopressin, urine specific gravity and osmolality increased abruptly, and daily urine output declined to the normal range. The desmopressin acetate was tapered gradually and discontinued 3 months later. Graft function was good, and urine output was maintained within the normal range without desmopressin 20 months after the transplantation. We present a case of a massive polyuria due to transient deficiency of antidiuretic hormone with the necessity of desmopressin therapy immediately after kidney transplantation in a pediatric patient.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권2호
• /
• pp.132-140
• /
• 2006

Well-differentiated thyroid cancer is the most common endocrine malignancy with an increasing incidence. Most patients with well-differentiated thyroid caner have a favorable prognosis with high survival rate. While surgery and radioiodine therapy is sufficient treatment for the majority of patients with differentiated thyroid cancer, a minority of these patients experiences progressive, life-threatening growth and metastatic spread of the disease. Because there is no prospective controlled study to evaluate the differences of management of thyroid cancer, it is hard to choose the best treatment option. And there are still lots of controversies about the management of this disease, such as surgical extent, proper use of radioiodine for remnant ablation and therapy, use of rhTSH instead of withdrawal of thyroid hormone, long-term follow-up strategy, thyroglobulin as a tumor marker, etc. In this review, recent data related to these conflicting issues and recent advances in diagnosis, radioiodine therapy and long-term monitoring of well-differentiated thyroid cancer are summarized.

• 대한물리치료과학회지
• /
• 제5권4호
• /
• pp.729-750
• /
• 1998

The purpose of this Review is to help activities of daily living by normalizing bodily functions through the use of negative pressure. Cupping therapy has been holding the important role as a form of treatment in ancient medicine of Oriental and Occidental country, and still being used widely due to it's effectiveness. Principle of Cupping therapy is to neutralize somatic dysfunctions by elimination of nonphysiological somatic fluid of hematoma through application of negative pressure on region of dermatomal meridian. The effectiveness of Cupping therapy as follows; 1) Effects on acid base balance of bodily fluid. 2) Through the reabsorption of subcutaneous hematoma, it affects on formation of immune system and produce the blood serum cleaning reaction. 3) By application of negative pressure on subcutaneous, induce renal system to produce steroid hormone. 4) By stimulating hemopoietic system, it maxmize the blood production level. Recently, Alternative medicine has been a focus due to it's nature of effectiveness and safety without adverse complication. Therefore, every family possess and use the cupping modality for preventive measure and/or treatment purpose in order to eliminate accumulated byproducts of body and clean the blood system.

• 대한한방부인과학회지
• /
• 제18권4호
• /
• pp.242-252
• /
• 2005

Purpose : Dysfunctional uterine bleeding is an abnormal uterine bleeding without an organic disease. A hormone therapy or anti-depressant medicine is chosen to treat dysfunctional uterine bleeding. However sometimes it didn't work. Hysterectomy is recommended to stop bleeding but a lot of women are afraid of it. The purpose of this study is to show the possibility of oriental medical treatment for dysfunctional uterine bleeding in this case report. Methods : The 30-year-old female patient who had suffering from uterine bleeding was treated with hormone therapy and anti-depressant medicine. However she was bleeding again. She had no organic disease in some medical examination, finally she was recommended a hysterectomy. But she didn't want the operation. In addition, she started acute abdominal pain. She wanted a oriental medical treatment and we treated her from the May 14th 2005 to the June 4th 2005 in admission. We used Yikweseungyangtang(益胃升陽湯), Ojuksan(五積散), Kwibitang hap Gyoesamultang(歸婢湯合膠艾四物湯) for herb-medication. In acupuncture therapy,　ST36(Chok-Samni 足三里) SP1(Eunbek, 隱白) SP6(Samumgyo, 三陰交) SP10(Hyulhae, 血海) Liv1(Daedon, 大敦) Liv3(Taechung, 太衝) LI4(Hapgok, 合谷) was selected. In moxa therapy CV4(Kwanwon, 關元), CV6(Kihae, 氣海), CVl2(Chung-wan, 中脘) was used.　Results : After oriental medical treatment for 22 days, she stopped uterine bleeding　and recovered her health．　Conclusion ：　Oriental medical treatment is expected to have an effect on　dysfuctional uterine bleeding with abdominal pain.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권8호
• /
• pp.3353-3358
• /
• 2014

Breast cancer is the most common in women worldwide, with some 5-10% of all cases due to inherited mutations of BRCA1 and BRCA2 genes. Obesity, hormone therapy and use of alcohol are possible causes and over-expression of leptin in adipose tissue may also play a role. Normally surgery, radiation therapy and chemotherapy allow a good prognosis where screening measures are in place. New hope in treatment measures include adjuvant therapy, neoadjuvant therapy, and introduction of mono-clonal antibodies and enzyme inhibitors.

• 혜화의학회지
• /
• 제13권2호
• /
• pp.1-10
• /
• 2004

During the reproductive years, the most common uterine myoma are benign, but the possibility of malignancy must be considered. Generally uterine myoma are also benign, and two-thirds of these occur in women between 30 and 45 years of age. Which produce few of only mild, nonspecific symptoms. The most common symptoms include abdominal pain or discomfort, low abdominal pressure sensation, hypermenorrhea and urinary symptoms comprise. The treatment of uterine myoma is just observation, operation and taking the hormone replacement therapy in western medicine.This study is performed to evaluate the effectiveness of Resonance Therapy and herb-med on uterine myoma. After this treatment, the size of the uterine myoma were reduced with a significant data or dismissed. So it indicates Resonance Therapy and herb-med is effective on the patient with uterine myoma, but continuous observation and study are needed.